MOLECULAR DOCKING SENYAWA POTENSIAL ANTICOVID-19 SECARA IN SILICO
Abstract
Pandemi COVID-19 memacu peneliti menginvestigasi beberapa senyawa potensial yang dapat menghambat SARS-CoV-2. Tujuan dari penelitian ini adalah mengevaluasi senyawa menggunakan pendekatan molecular docking untuk menghambat domain makro SARS-CoV-2 (PDB: 7CZ4). Evaluasi dilakukan berdasarkan skor docking menggunakan AutoDock Vina. Konformasi terbaik dari kompleks reseptor ligan diindikasikan oleh afinitas tertinggi atau energi bebas Gibbs’/ΔG paling negatif. Hasil penelitian menunjukkan bahwa curcumin, rhamnetin, mycophenolic acid dan quercetin memiliki afinitas tertinggi. Selain itu, penelitian ini juga menunjukkan jumlah ikatan hidrogen dengan residu asam amino tertinggi sebagai indikator stabilitas secara berturut-turut: 4S0765P9W8, curcumin, rhamnetin dan mycophenolic acid. Hasil ini merupakan screening awal potensi senyawa tersebut sebagai anticovid-19 sehingga perlu dilengkapi dengan uji in vitro dan in vivo.References
Abouelela, M. E., Assaf, H. K., Abdelhamid, R. A., Elkhyat, E. S., Sayed, A. M., Oszako, T., Belbahri, L., El Zowalaty, A. E., & Abdelkader, M. S. A. (2021). Identification of potential SARS-CoV-2 main protease and spike protein inhibitors from the genus aloe: An in silico study for drug development. Molecules, 26(6). https://doi.org/10.3390/molecules26061767
Azeez, S. A., Alhashim, Z. G., Al Otaibi, W. M., Alsuwat, H. S., Ibrahim, A. M., Almandil, N. B., & Francis Borgio, J. (2020). State-of-the-art tools to identify druggable protein ligand of SARS-CoV-2. Archives of Medical Science, 16(2), 497–507. https://doi.org/10.5114/aoms.2020.94046
Guedes, I. A., de Magalhães, C. S., & Dardenne, L. E. (2014). Receptor-ligand molecular docking. Biophysical Reviews, 6(1), 75–87. https://doi.org/10.1007/s12551-013-0130-2
Lin, M. H., Chang, S. C., Chiu, Y. C., Jiang, B. C., Wu, T. H., & Hsu, C. H. (2020). Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain. ACS Infectious Diseases, 6(11), 2970–2978. https://doi.org/10.1021/acsinfecdis.0c00441
Purwaniati, P., & Asnawi, A. (2020). Target Kerja Obat Covid-19: Review. Jurnal Farmagazine, 7(2), 30. https://doi.org/10.47653/farm.v7i2.172
Smith, T., Bushek, J., Leclaire, A., & Prosser, T. (2020). COVID-19 Drug Therapy What ’ s been updated : Highlights : Elseivier, 1–25.
Tallei, T. E., Tumilaar, S. G., Niode, N. J., Fatimawali, Kepel, B. J., Idroes, R., Effendi, Y., Sakib, S. A., & Emran, T. Bin. (2020). Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study. Scientifica, 2020. https://doi.org/10.1155/2020/6307457
WHO. (2020). COVID-19 Weekly Epidemiological Update 35. World Health Organization, December, 1–3. https://www.who.int/docs/default-source/coronaviruse/situation-reports/weekly_epidemiological_update_22.pdf
Copyright (c) 2021 JIKA (Jurnal Informatika)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License and Copyright Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- That it is not under consideration for publication elsewhere,
- That its publication has been approved by all the author(s) and by the responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with International Journal of Advances in Intelligent Informatics agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.Â
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Licensing for Data Publication
International Journal of Advances in Intelligent Informatics use a variety of waivers and licenses, that are specifically designed for and appropriate for the treatment of data:
Open Data Commons Attribution License, http://www.opendatacommons.org/licenses/by/1.0/ (default)
Creative Commons CC-Zero Waiver, http://creativecommons.org/publicdomain/zero/1.0/
Open Data Commons Public Domain Dedication and Licence, http://www.opendatacommons.org/licenses/pddl/1-0/
Other data publishing licenses may be allowed as exceptions (subject to approval by the editor on a case-by-case basis) and should be justified with a written statement from the author, which will be published with the article.
Open Data and Software Publishing and Sharing
The journal strives to maximize the replicability of the research published in it. Authors are thus required to share all data, code or protocols underlying the research reported in their articles. Exceptions are permitted but have to be justified in a written public statement accompanying the article.
Datasets and software should be deposited and permanently archived inappropriate, trusted, general, or domain-specific repositories (please consult http://service.re3data.org and/or software repositories such as GitHub, GitLab, Bioinformatics.org, or equivalent). The associated persistent identifiers (e.g. DOI, or others) of the dataset(s) must be included in the data or software resources section of the article. Reference(s) to datasets and software should also be included in the reference list of the article with DOIs (where available). Where no domain-specific data repository exists, authors should deposit their datasets in a general repository such as ZENODO, Dryad, Dataverse, or others.
Small data may also be published as data files or packages supplementary to a research article, however, the authors should prefer in all cases a deposition in data repositories.
